how many people have gone blind from semaglutide A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Comparative ocular outcomes of tirzepatide

It may support endurance, reduce fatigue, and improve recovery when combined with regular training

Thyroid Cancer Risk: Human Studies Shared Decision-Making: The Patient With Cancer Who Is Also Receiving a GLP-1 RA It is important to discuss these potential adverse events (such as excess nausea and vomiting, nutritional deficiencies, changes in bioavailability of oral chemotherapies) with the patient newly diagnosed with cancer who is receiving a GLP-1 RA before initiating chemotherapy to determine the optimal treatment plan

that reported that oral L-carnitine administration could not significantly reduce lp(a) concentration in type IIdiabetic patients [44]

Wang said several types of studies are needed to further explore the link between GLP-1s and obesity-associated cancers

LEAP2 exerts its effects by functioning as a GHS-1Ra antagonist